Page 2 - Eisai Biogen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The drug, lecanemab, which was recently granted accelerated approval in the United States, is an antibody that has been shown to remove sticky deposits of a protein called amyloid beta from the brains of patients in the early stages of the mind-wasting disease. FDA advisers back the same COVID vaccine for initial shots, boosters Advisers to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of targeting the same coronavirus strain for initial COVID-19 vaccine doses and boosters going forward, but some expressed skepticism about whether all Americans need to receive the shots annually.

United statesEnvironmental protection agencyDistrict of columbiaBruxelles capitaleWhite houseMichael reganRegeneron dupixentKamala harrisUs environmental protection agencyUs centers for diseaseEuropean commissionDrug administrationBiogen incDrug administration onEisai co ltdEuropean union